FDA Panel Endorses Gene Therapy For A Form Of Childhood Blindness – NPR

Tweet about this on TwitterPin on Pinterest0Share on Reddit0Share on Tumblr0Share on Google+0Share on StumbleUpon0Share on Facebook0Share on LinkedIn0Digg thisShare on Yummly0Share on VKFlattr the authorEmail this to someonePrint this page

NPR

FDA Panel Endorses Gene Therapy For A Form Of Childhood Blindness
NPR
A panel of experts has recommended that the Food and Drug Administration approve a treatment developed by Spark Therapeutics for a rare form of blindness. Spark Therapeutics hide caption. toggle caption. Spark Therapeutics. A panel of experts has …
FDA Advisers Endorse Gene Therapy to Treat Form of BlindnessU.S. News & World Report
Spark’s Gene Therapy to Treat Blindness Gets Closer to ApprovalBloomberg
FDA Considers Gene Therapy for Rare Eye DiseaseWebMD
Nature.com –Washington Post –Financial Times –Investor’s Business Daily
all 79 news articles »

View original article
Author: